Success Stories

Biogen grows international headquarters in Greater Zurich Area

Biogen is where science meets humanity. As pioneers in neuroscience, the company has developed the world’s leading portfolio of treatments for Multiple Sclerosis and developed the world’s first approved treatment for Spinal Muscular Atrophy. Today, Biogen is developing innovative treatments for Alzheimer’s Disease, ALS and many other conditions.

Biogen established its international headquarters in the Greater Zurich Area in 2004. Since then the company has grown to more than 450 permanent employees based in Baar, Zug. It is currently investing around 1.5 billion CHF in a next-generation manufacturing facility in Solothurn, adding approximately 400 permanent new jobs by the time it will be fully operational.

“Biogen is where science meets humanity. With its rich history in neuroscience and its position at the heart of Europe, Switzerland is the ideal hub for us to bring our life-changing treatments in MS, SMA and other neurological diseases to people in more than 60 countries around the world.”

Johanna Friedl-Naderer President of Europe, Canada & Partner Markets

The perfect match

Switzerland was an obvious choice for Biogen due to its political stability, predictability and business-friendly environment. The country also has a long tradition in pharmaceuticals development and strong track record on fostering innovation. Greater Zurich Area’s central location in Europe and the excellent connectivity by train and air to the most important European markets have helped Biogen develop its business across the region. Biogen has also valued Switzerland as a home to experienced, well-educated and highly diverse talent.

Commitment to science

In keeping with Biogen’s commitment to inspiring young people to consider innovative careers in science, the international headquarters has developed and cultivated long-standing relationships with some of the premier STEM (science, technology, education and math) programs in Switzerland including Swiss Science Center Technorama.

“At our headquarters in Baar, we have built a team of more than 450 professionals from all over the world. Being in Switzerland, we have access to an incredibly talented, diverse and well-educated group of people – ideal for a company where science meets humanity.”

Alessandro Marcuzzi Head of Alzheimer’s Disease, Europe, Canada & Partner Markets & Site Lead International HQ

Read more from the Greater Zurich Area below.